RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU3FA6B338DD3B6EC5

https://w3id.org/ripe/ripe-kg/author/RIPEAU3FA6B338DD3B6EC5
SubjectPredicateObject
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type node1
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type rdfs:Resource
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type owl:Thing
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type prov:Person
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type foaf:Person
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen owl:sameAs https://semopenalex.org/author/A5112710988
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen foaf:familyName Wen
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen foaf:givenName Bi-Xiu
ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen foaf:name Bi-Xiu Wen
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial dcterms:creator ripekg:author/RIPEAU3FA6B338DD3B6EC5Bi-Xiu Wen